The effect of montelukast on exhaled nitric oxide of alveolar and bronchial origin in inhaled corticosteroid-treated asthma

Respiratory Medicine

Volumn 103, Issue 2, 2009, Pages 296-300

  Fritscher, Leandro G ^a,b   Rodrigues, Marcelo T ^a   Zamel, Noe ^a,b   Chapman, Kenneth R ^a  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b PONTIFICAL CATHOLIC UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

Inflammation; Peripheral; Small airways; Systemic

Indexed keywords

CORTICOSTEROID; FLUTICASONE PROPIONATE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MONTELUKAST; NITRIC OXIDE;

ADULT; AGED; ARTICLE; ASTHMA; BRONCHUS; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; LUNG ALVEOLUS; LUNG FUNCTION; LUNG VOLUME; MALE; MEASUREMENT; METERED DOSE INHALER; MONOTHERAPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SCORING SYSTEM; SPIROMETRY; STATISTICAL SIGNIFICANCE; SYSTEMIC THERAPY; TREATMENT DURATION; TREATMENT RESPONSE;

ACETATES; ADMINISTRATION, INHALATION; ADRENAL CORTEX HORMONES; ADULT; ANDROSTADIENES; ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHI; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LEUKOTRIENE ANTAGONISTS; MALE; NITRIC OXIDE; PROSPECTIVE STUDIES; QUINOLINES;

EID: 58249092645     PISSN: 09546111     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rmed.2008.08.007     Document Type: Article

References (26)

1. Carroll N., Carello S., Cooke C., and James A. Airway structure and inflammatory cells in fatal attacks of asthma. Eur Respir J 9 4 (1996) 709-715
2. Carroll N., Cooke C., and James A. The distribution of eosinophils and lymphocytes in the large and small airways of asthmatics. Eur Respir J 10 2 (1997) 292-300
3. Faul J.L., Tormey V.J., Leonard C., Burke C.M., Farmer J., Horne S.J., et al. Lung immunopathology in cases of sudden asthma death. Eur Respir J 10 2 (1997) 301-307
4. Kraft M., Djukanovic R., Wilson S., Holgate S.T., and Martin R.J. Alveolar tissue inflammation in asthma. Am J Respir Crit Care Med 154 5 (1996) 1505-1510
5. Kraft M., Martin R.J., Wilson S., Djukanovic R., and Holgate S.T. Lymphocyte and eosinophil influx into alveolar tissue in nocturnal asthma. Am J Respir Crit Care Med 159 1 (1999) 228-234
6. Mauad T., Silva L.F., Santos M.A., Grinberg L., Bernardi F.D., Martins M.A., et al. Abnormal alveolar attachments with decreased elastic fiber content in distal lung in fatal asthma. Am J Respir Crit Care Med 170 8 (2004) 857-862
7. ten Brinke A., Zwinderman A.H., Sterk P.J., Rabe K.F., and Bel E.H. "Refractory" eosinophilic airway inflammation in severe asthma: effect of parenteral corticosteroids. Am J Respir Crit Care Med 170 6 (2004) 601-605
8. King G.G., and Salome C.M. Multimodality measurements of small airways disease. Eur Respir J 27 2 (2006) 250-252
9. Sandrini A., Ferreira I.M., Gutierrez C., Jardim J.R., Zamel N., and Chapman K.R. Effect of montelukast on exhaled nitric oxide and nonvolatile markers of inflammation in mild asthma. Chest 124 4 (2003) 1334-1340
10. Gelb A.F., Taylor C.F., Nussbaum E., Gutierrez C., Schein A., Shinar C.M., et al. Alveolar and airway sites of nitric oxide inflammation in treated asthma. Am J Respir Crit Care Med 170 7 (2004) 737-741
11. Smith A.D., Cowan J.O., Filsell S., McLachlan C., Monti-Sheehan G., Jackson P., et al. Diagnosing asthma: comparisons between exhaled nitric oxide measurements and conventional tests. Am J Respir Crit Care Med 169 4 (2004) 473-478
12. Covar R.A., Szefler S.J., Martin R.J., Sundstrom D.A., Silkoff P.E., Murphy J., et al. Relations between exhaled nitric oxide and measures of disease activity among children with mild-to-moderate asthma. J Pediatr 142 5 (2003) 469-475
13. Tsoukias N.M., and George S.C. A two-compartment model of pulmonary nitric oxide exchange dynamics. J Appl Physiol 85 2 (1998) 653-666
14. 2 in humans: effect of dynamically changing flow rate. J Appl Physiol 85 2 (1998) 642-652
15. Lehtimaki L., Kankaanranta H., Saarelainen S., Turjanmaa V., and Moilanen E. Increased alveolar nitric oxide concentration in asthmatic patients with nocturnal symptoms. Eur Respir J 20 4 (2002) 841-845
16. Mahut B., Delacourt C., Zerah-Lancner F., de Blic J., Harf A., and Delclaux C. Increase in alveolar nitric oxide in the presence of symptoms in childhood asthma. Chest 125 3 (2004) 1012-1018
17. Lehtimaki L., Kankaanranta H., Saarelainen S., Turjanmaa V., and Moilanen E. Inhaled fluticasone decreases bronchial but not alveolar nitric oxide output in asthma. Eur Respir J 18 4 (2001) 635-639
18. Berry M., Hargadon B., Morgan A., Shelley M., Richter J., Shaw D., et al. Alveolar nitric oxide in adults with asthma: evidence of distal lung inflammation in refractory asthma. Eur Respir J 25 6 (2005) 986-991
19. Brindicci C., Ito K., Barnes P.J., and Kharitonov S.A. Differential flow analysis of exhaled nitric oxide in patients with asthma of differing severity. Chest 131 5 (2007) 1353-1362
20. Malmstrom K., Rodriguez-Gomez G., Guerra J., Villaran C., Pineiro A., Wei L.X., et al. Oral montelukast, inhaled beclomethasone, and placebo for chronic asthma. A randomized, controlled trial. Montelukast/Beclomethasone Study Group. Ann Intern Med 130 6 (1999) 487-495
21. Juniper E.F., Svensson K., Mork A.C., and Stahl E. Measurement properties and interpretation of three shortened versions of the asthma control questionnaire. Respir Med 99 5 (2005) 553-558
22. ATS/ERS recommendations for standardized procedures for the online and offline measurement of exhaled lower respiratory nitric oxide and nasal nitric oxide, 2005. Am J Respir Crit Care Med 171 8 (2005) 912-930
23. Hauber H.P., Gotfried M., Newman K., Danda R., Servi R.J., Christodoulopoulos P., et al. Effect of HFA-flunisolide on peripheral lung inflammation in asthma. J Allergy Clin Immunol 112 1 (2003) 58-63
24. Goldin J.G., Tashkin D.P., Kleerup E.C., Greaser L.E., Haywood U.M., Sayre J.W., et al. Comparative effects of hydtrrofluoroalkane and chlorofluorocarbon beclomethasone dipropionate inhalation on small airways: assessment with functional helical thin-section computed tomography. J Allergy Clin Immunol 104 6 (1999) S258-S267
25. Zeidler M.R., Kleerup E.C., Goldin J.G., Kim H.J., Truong D.A., Simmons M.D., et al. Montelukast improves regional air-trapping due to small airways obstruction in asthma. Eur Respir J 27 2 (2006) 307-315
26. Kraft M., Cairns C.B., Ellison M.C., Pak J., Irvin C., and Wenzel S. Improvements in distal lung function correlate with asthma symptoms after treatment with oral montelukast. Chest 130 6 (2006) 1726-1732